| |
|
|
|
|
|
As with all Siemens Healthcare Diagnostics assays, ADVIA Centaur BNP provides precision and performance for automated productivity:
|
Company:
Date:
November 13, 2008
|
|
|
|
|
|
|
|
|
|
This paper outlines the clinical studies performed to evaluate the performance
of the recently introduced MEIA assay, on the AxSYM analyzer, for measurement
of B-type natriuertic peptide (BNP) in plasma samples.
■ The evaluations were performed using clinical samples obtained from
9 different collection sites and all testing was performed using the Abbott
AxSYM instruments on site at Axis-Shield, Dundee. All clinical specimens
were supplied with demographic information (including age, gender, ethnic
origin and treatment history) and comprised both diagnosed heart failure, i.e.,
congestive hear
|
Company:
Date:
November 13, 2008
|
|
|
|
|
|
|
|
|
|
A novel immunological approach for the management of heart failure, allowing patient diagnosis, prognosis assessment and monitoring.
|
Company:
Date:
November 13, 2008
|
|
|
|
|
|
|
|
|
|
B-type Natriuretic Peptide Recombinant Human produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 32 amino acids and having a molecular mass of 3464 kDa.
NPPB is purified by proprietary chromatographic techniques.
|
Company:
Date:
November 13, 2008
|
|
|
|
|